Scott Cowan focuses his practice on corporate finance transactions, mergers and acquisitions and securities law matters primarily in the technology, life sciences and healthcare industries. Scott advises a broad range of clients, including startup and emerging companies, publicly held middle-market companies and venture capital and private equity firms. Scott’s transactional experience includes IPOs, PIPEs, registered direct offerings and direct follow-on offerings, as well as venture capital, private equity, mergers and acquisitions, and other strategic transactions. He regularly serves as outside general counsel for private and public companies at various stages of development. Scott also assists clients in the preparation and filing of 1933 Act and 1934 Act documents and proxy materials with the United States Securities and Exchange Commission and related compliance.